AstraZeneca Profit Falls on Generic Competition

AstraZeneca Profit Falls on Generic Competition Play

Feb. 6 (Bloomberg) -- AstraZeneca said fourth-quarter profit fell as sales of its best-selling medicines and growth in emerging markets failed to compensate for increasing generic competition. Anna Edwards reports on Bloomberg Television's "Countdown." (Source: Bloomberg)

  • On Air Now

    Market Makers Watch Now

  • Next

    Money Clip

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus